Literature DB >> 2423106

Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates.

V M Doctor, A R Sheth, M M Simha, N J Arbatti, J P Aaveri, N A Sheth.   

Abstract

A specific antiserum has been generated against inhibin-like material (ILM) of prostatic origin. Using the immunoperoxidase technique, localization of ILM has been examined in a total of 114 prostates including normal (4 specimens), malignant (46) and hyperplastic (55) tissues. ILM positive immunocytochemical reactions were confined to the cytoplasm and not the nucleus of the prostatic acinar cells in the three categories of prostate, whereas the stroma showed negative reactions. The intensity of positive reactions decreased in the following order: Hyperplasia, incidental and moderately differentiated carcinomas, poorly differentiated carcinomas, whereas metaplasia and granulomatous prostatitis gave negative reactions for ILM. Using this experimental protocol, 200 non-prostatic tissue were found to be completely negative, demonstrating the specificity of the test for prostatic epithelium. These findings indicate a potential use of ILM as a marker of prostatic tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423106      PMCID: PMC2001445          DOI: 10.1038/bjc.1986.85

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen.

Authors:  J Johansson; A Sheth; E Cederlund; H Jörnvall
Journal:  FEBS Lett       Date:  1984-10-15       Impact factor: 4.124

2.  Characterization of a polypeptide from human seminal plasma with inhibin (inhibition of FSH secretion)-like activity.

Authors:  A R Sheth; N Arabatti; M Carlquist; H Jörnvall
Journal:  FEBS Lett       Date:  1984-01-02       Impact factor: 4.124

3.  Isolation & characterization of inhibin from human seminal plasma.

Authors:  A N Thakur; A Y Vaze; B Dattatreyamurthy; A R Sheth
Journal:  Indian J Exp Biol       Date:  1981-04       Impact factor: 0.818

4.  Levels of inhibin in human semen and accessory reproductive organs.

Authors:  A Y Vaze; A N Thakur; A R Sheth
Journal:  Andrologia       Date:  1980 Jan-Feb       Impact factor: 2.775

5.  Role of the prostate in the regulation of pituitary secretion of follicle stimulating hormone.

Authors:  A R Sheth; G R Vanage; K S Hurkadli; N A Sheth
Journal:  Med Hypotheses       Date:  1984-10       Impact factor: 1.538

6.  Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.

Authors:  M Nadji; S Z Tabei; A Castro; T M Chu; G P Murphy; M C Wang; A R Morales
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

7.  Studies on inhibin-like peptide in gastric juice and serum of patients with duodenal ulcers.

Authors:  S A Shanbhag; A R Sheth; S A Nanivadekar; N A Sheth
Journal:  J Endocrinol       Date:  1984-12       Impact factor: 4.286

8.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

9.  Inhibin in the human prostate.

Authors:  A R Sheth; G T Panse; A Y Vaze; J Geller; J Albert
Journal:  Arch Androl       Date:  1981-06

10.  Immunoreactive inhibin-like material in serum and gastric juice of patients with benign and malignant diseases of the stomach.

Authors:  S A Shanbhag; A R Sheth; S A Nanivadekar; N A Sheth
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

View more
  10 in total

Review 1.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

2.  Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.

Authors:  Bhakti R Pathak; Ananya A Breed; Vaishali H Nakhawa; Dhanashree D Jagtap; Smita D Mahale
Journal:  Asian J Androl       Date:  2010-08-02       Impact factor: 3.285

3.  Beta microseminoprotein is not a prostate-specific protein. Its identification in mucous glands and secretions.

Authors:  H Weiber; C Andersson; A Murne; G Rannevik; C Lindström; H Lilja; P Fernlund
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

4.  Characterization of ostrich (Struthio camelus) beta-microseminoprotein (MSP): identification of homologous sequences in EST databases and analysis of their evolution during speciation.

Authors:  C Lazure; M Villemure; D Gauthier; R J Naudé; M Mbikay
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 5.  MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Authors:  Siobhan Sutcliffe; Angelo M De Marzo; Karen S Sfanos; Martin Laurence
Journal:  Prostate       Date:  2014-01-24       Impact factor: 4.104

6.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.

Authors:  Anders S Bjartell; Hikmat Al-Ahmadie; Angel M Serio; James A Eastham; Scott E Eggener; Samson W Fine; Lene Udby; William L Gerald; Andrew J Vickers; Hans Lilja; Victor E Reuter; Peter T Scardino
Journal:  Clin Cancer Res       Date:  2007-07-15       Impact factor: 12.531

8.  The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.

Authors:  Hayley C Whitaker; Zsofia Kote-Jarai; Helen Ross-Adams; Anne Y Warren; Johanna Burge; Anne George; Elizabeth Bancroft; Sameer Jhavar; Daniel Leongamornlert; Malgorzata Tymrakiewicz; Edward Saunders; Elizabeth Page; Anita Mitra; Gillian Mitchell; Geoffrey J Lindeman; D Gareth Evans; Ignacio Blanco; Catherine Mercer; Wendy S Rubinstein; Virginia Clowes; Fiona Douglas; Shirley Hodgson; Lisa Walker; Alan Donaldson; Louise Izatt; Huw Dorkins; Alison Male; Kathy Tucker; Alan Stapleton; Jimmy Lam; Judy Kirk; Hans Lilja; Douglas Easton; Colin Cooper; Rosalind Eeles; David E Neal
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.

Authors:  K S Hurkadli; A R Sheth; S V Garde; V M Doctor; N A Sheth
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

10.  Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.

Authors:  Martin Laurence; Mark Asquith; James T Rosenbaum
Journal:  Front Med (Lausanne)       Date:  2018-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.